This practice charges private rates, so treat what follows with appropriate suspicion. It argues against a large part of how premium treatment is sold, including some of what could be sold by us.
What the money usually buys
At the top of the market you are typically paying for the setting, the accommodation, the food, the privacy, the ratio of staff to clients, and the absence of anything institutional.
Two of those are worth real money.
Privacy is not a luxury for this client group. It is often the reason private payment is chosen at all — no insurance claim, no diagnosis code travelling between administrative systems, no waiting room. That is a substantive purchase.
Staff ratio plausibly matters, though it is hard to isolate in the evidence.
The rest — the view, the linen, the chef — buys comfort and dignity. Those are not nothing. A person more willing to stay somewhere pleasant is a person in treatment rather than out of it. But they are not the mechanism.
What the evidence associates with outcomes
Look at the population with the best documented long-term results, which is physicians treated through state Physician Health Programs.
McLellan and colleagues (2008) followed 802 of them. At five years, 78.7% were licensed without restriction and working. DuPont and colleagues (2009) described what those programmes actually consist of:
- About five years of monitoring, after the treatment episode ends.
- Random testing — roughly 48 times in year one, about 20 a year by year five.
- A written contract setting out the care, the monitoring, and the consequences.
- A response to a positive test that is more treatment, not expulsion.
- Active case management throughout.
Note what is not on that list. Nothing about the building. Nothing about the food. Nothing about the view.
And a detail worth holding onto: 95% of physicians who completed their contract were still licensed at five years. The variable that predicted the outcome was completing a five-year structure — not where the first thirty days happened.
The matching question
Families also worry about picking the right type of programme.
Project MATCH was built to test that. It randomised people to three well-designed treatments and found little difference in outcome by type of treatment, with all three producing significant sustained improvement. Only psychiatric severity showed a meaningful interaction.
So the agonising over philosophy is largely misplaced, and the agonising over what happens in month nine is not.
The honest read
Two facilities, same price.
Facility A: extraordinary setting, private chef, thirty days, a discharge plan handed over on the last morning, and an invitation to call if needed.
Facility B: comfortable and unremarkable, thirty days, and then two years of active case management, scheduled contact, agreed monitoring and a named person who notices when contact stops.
By the evidence above, B is the better purchase. It will photograph worse and it is harder to sell, because the valuable part is invisible and happens after everyone has gone home.
What to ask
“What happens in month nine, and who is responsible for it?” If the answer is a document, that is not continuity.
“Will anyone who knows them still be involved in six months?”
“What happens if they miss two check-ins?” Days or months. It matters enormously.
“Is medication available if it’s indicated?” A philosophical objection is a clinical decision being made on your behalf.
“What is the total duration of involvement?” Not the residential stay — the whole arrangement.
The question underneath
Families rarely ask “is luxury rehab worth it” in the abstract. What they are usually asking is something more painful: if we spend more, is he more likely to live?
The honest answer is that spending more buys privacy, comfort and dignity reliably, and buys better outcomes only insofar as it buys duration, monitoring and continuity. Those are purchasable — they are simply not what the premium market leads with, because a two-year case management arrangement does not photograph.
There is a related trap worth naming. Very expensive treatment can create a sense that the problem has been dealt with — a large cheque feels like a decisive act. The physician data cuts directly against that. What predicted outcome was not the intensity of the initial episode; it was completing a five-year structure. The cheque is the beginning of the work, not its conclusion.
Where that leaves us
Our own offer is duration, monitoring and case management. So the argument above is self-serving, and you should weigh it accordingly.
What is not self-serving: if you are choosing between a beautiful thirty days and a plain thirty days plus two years of structure, and you can only afford one, the evidence favours the second — whoever provides it, us or anyone else.
Comfort is worth paying for once the structural questions are answered. It is a poor substitute for them.
References
- McLellan AT, Skipper GS, Campbell M, DuPont RL (2008). Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ, 337, a2038. 10.1136/bmj.a2038
- DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS (2009). How are addicted physicians treated? A national survey of Physician Health Programs. Journal of Substance Abuse Treatment, 37, 1-7. 10.1016/j.jsat.2009.03.010
- Project MATCH Research Group (1997). Matching Alcoholism Treatments to Client Heterogeneity. Journal of Studies on Alcohol, 58, 7-29. 10.15288/jsa.1997.58.7
Read more about Rehab Placement.
